David Han joined OEP in 2005 and is a Senior Managing Director based in New York and a member of the Investment Committee, the Operating Committee and the Valuation Committee. Mr. Han led OEP’s investments in OCI, Columbian Chemicals, Pirelli Tyre, Celltrion Healthcare, Sonneborn, PeroxyChem and ORS Medco. He is a member of the Board of Directors of Celltrion Healthcare and ORS Medco and previously served as Chairman of PeroxyChem and on the Boards of OCI, Columbian Chemicals, Pirelli Tyre and Sonneborn.
Prior to joining OEP, Mr. Han spent 18 years as a Mergers and Acquisitions banker. He began his investment banking career as an Associate at Lehman Brothers and was a Vice President at Morgan Stanley, a Managing Director at Smith Barney, a Managing Director at Greenhill, and a Managing Director at Credit Suisse First Boston. He received his M.B.A. from Harvard Business School and his B.A. in Economics from Cornell University.